RE:More delays.. The news is not ideal, but they're still going to get the financing to push forward. Q4 2020 or Q1 2021 isn't such a big deal.
key thing to takeaway, integrasyn is cheaper and more efficient than competitors and fundamentals in that process and drug candidates are strong.